Free Float -
Shares Float -
Shares Outstanding 12,04 M
Prolight Diagnostics
Fund · SE0003618230 (XSTO)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Prolight Diagnostics
No Price
Share Float & Liquidity
Company Profile for Prolight Diagnostics Fund
Prolight Diagnostics AB develops patient-based test systems based on patented technology. It offers integrated diagnostic support consisting of handy measuring instruments and disposable chips for diagnosis of heart attacks and also for long-term evaluation of the risks for heart disease. The company was founded by Masoud Khayyami in 1999 and is headquartered in Lund, Sweden.
Company Data
Name Prolight Diagnostics
Company Prolight Diagnostics
Website
http://www.pldab.com
Primary Exchange 
NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
ISIN SE0003618230
Asset Class Fund
Sector Healthcare
Industry Medical - Specialties
CEO Ulf Bladin
Country Sweden
Currency SEK
Employees -
Address , Lund
IPO Date 2017-03-31
Stock Splits
| Date | Split |
|---|---|
| 10.12.2025 | 1:100 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ STOCKHOLM AB | PRLD.ST |
More Shares
Investors who hold Prolight Diagnostics also have the following shares in their portfolio:
